Pharmacogenetic detection chip for cardiac and cerebral vascular diseases and its application

Abstract

The present invention relates to gene polymorphism detecting chip, and discloses one kind of pharmacogenetic detecting chip for cardiac and cerebral vascular diseases and comprising solid carrier and probe. The probe can hybridize with the nucleotide sequence and / or its complementary sequence of the gene related to cardiac and cerebral vascular disease pharmacogenetics. The present invention also discloses the method of using the chip in detecting the gene related to cardiac and cerebral vascular disease pharmacogenetics. The detecting chip of the present invention makes it possible for the medical staff to obtain cardiac and cerebral vascular disease pharmacogenetics of the patient for predicting clinical medicine treatment and individualized treatment.

Description

technical field

[0001] The invention relates to a gene polymorphism detection chip, in particular to a pharmacogenetic detection chip for cardiovascular and cerebrovascular diseases and its application. Background technique

[0002] Cardiovascular and cerebrovascular diseases are the number one disease that threatens middle-aged and elderly people. With its high incidence, high disability rate and high mortality rate as the most typical three high diseases, it has brought great harm to patients, families and society. Epidemiological surveys show that the average incidence of cardiovascular and cerebrovascular diseases in the world population is 10-20%; the number of people who die from cardiovascular and cerebrovascular diseases accounts for 52% of the death toll every year in the world, and is the number one killer of death. With the improvement of people's life, the change of diet structure and ecological environment, the number of patients with cardiovascular and cerebrov...

Images